HCA Healthcare, Inc. beat EPS estimates 81% of the time across 16 reported quarters (13 beats, 3 misses), averaging +7.2% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $7.57 | $7.59 | +0.3% | Beat | Q2 FY26 call |
| Q1 FY26 | $7.17 | $7.15 | -0.3% | Miss | |
| Q4 FY25 | $7.36 | $8.01 | +8.8% | Beat | Q4 FY25 call |
| Q3 FY25 | $5.65 | $6.96 | +23.2% | Beat | Q3 FY25 call |
| Q2 FY25 | $6.19 | $6.84 | +10.5% | Beat | Q2 FY25 call |
| Q1 FY25 | $5.77 | $6.45 | +11.8% | Beat | |
| Q4 FY24 | $5.97 | $6.22 | +4.2% | Beat | Q4 FY24 call |
| Q3 FY24 | $4.97 | $5.05 | +1.6% | Beat | Q3 FY24 call |
| Q2 FY24 | $4.97 | $5.50 | +10.7% | Beat | Q2 FY24 call |
| Q1 FY24 | $5.01 | $5.36 | +7.0% | Beat | |
| Q4 FY23 | $5.05 | $5.90 | +16.8% | Beat | |
| Q3 FY23 | $3.97 | $3.91 | -1.5% | Miss |
Back to HCA overview · HCA holders · HCA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.